Pharmiwebcom

DeepHow has introduced PharmaCloud, a cloud-based platform designed specifically for pharmaceutical and medical device manufacturers to improve training, ex*****on, and verification on the factory floor. PharmaCloud provides a GMP-compliant environment that helps teams standardize procedures across sites so operators follow approved methods with greater consistency and fewer errors than traditional training.

The platform unifies training content, guided step-by-step ex*****on, and AI-powered...

https://www.pharmiweb.com/pwtoday-story/deephow-launches-pharmacloud-to-standardize-pharma-manufacturing-training?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost

Sanofi has secured European Union approval for Teizeild (teplizumab), a new disease-modifying therapy for people aged eight years and older with stage 2 type 1 diabetes. This decision by the European Commission follows a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use and makes Teizeild the first treatment in the EU shown to delay the onset of stage 3 clinical type 1 diabetes.

The approval is based on positive results from the TN-10 phase I...

https://www.pharmiweb.com/pwtoday-story/sanofi-s-teizeild-gains-first-eu-approval-to-delay-type-1-diabetes-progression?utm_source=linkedin&utm_medium=zapier&utm_campaign=pwtoday-autopost